1. Identification of Novel Cannabinoid CB2 Receptor Agonists from Botanical Compounds and Preliminary Evaluation of Their Anti-Osteoporotic Effects
    Si-Jing Hu et al, 2022, Molecules CrossRef
  2. Non-flavonoid polyphenols in osteoporosis: preclinical evidence
    Daniele Bellavia et al, 2021, Trends in Endocrinology & Metabolism CrossRef
  3. Botanicals in Postmenopausal Osteoporosis
    Wojciech Słupski et al, 2021, Nutrients CrossRef
  4. The Biological Efficacy of Natural Products against Acute and Chronic Inflammatory Diseases in the Oral Region
    Toshiaki Ara et al, 2018, Medicines CrossRef
  5. Development of mangiferin loaded chitosan-silica hybrid scaffolds: Physicochemical and bioactivity characterization
    Salita Demeyer et al, 2021, Carbohydrate Polymers CrossRef
  6. Effect of long-term administration of mangiferin from Belamcanda chinensis on bone metabolism in ovariectomized rats
    Beata Nowak et al, 2018, Journal of Functional Foods CrossRef
  7. Ethanolic extract of Pyrrosia lingua (Thunb.) Farw. ameliorates OVX-induced bone loss and RANKL-induced osteoclastogenesis
    Seon-A Jang et al, 2022, Biomedicine & Pharmacotherapy CrossRef
  8. Farnesoid X receptor agonist attenuates subchondral bone osteoclast fusion and osteochondral pathologies of osteoarthritis via suppressing JNK1/2/NFATc1 pathway
    Wenhui Hu et al, 2022, The FASEB Journal CrossRef
  9. The protective effects of mangiferin on metabolic and organs functions in the adolescent rat model of alcohol abuse
    Ce Chu et al, 2018, Journal of Functional Foods CrossRef
  10. A review of antidiabetic active thiosugar sulfoniums, salacinol and neokotalanol, from plants of the genus Salacia
    Toshio Morikawa et al, 2021, Journal of Natural Medicines CrossRef
  11. IMMUNOMODULATOR ACTIVITY OF MANGIFERIN FROM MANGO (MANGIFERA INDICA L.) IN CANCER: A SYSTEMATIC REVIEW
    YACHI QURRATA AYUNI LUBAKISAR et al, 2021, International Journal of Pharmacy and Pharmaceutical Sciences CrossRef
  12. Effects of urolithin A on osteoclast differentiation induced by receptor activator of nuclear factor-κB ligand via bone morphogenic protein 2
    Zhe Wang et al, 2022, Bioengineered CrossRef